News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acologix, Inc. And Toray Industries, Inc. (TRYIY) To Collaborate In Development Of Drug Candidate For Renal Disease



6/26/2006 5:52:00 PM

Tokyo, June 22, 2006 (JCN) - Toray Industries recently announced that it has concluded a licensing agreement with Acologix, a California biopharmaceutical company specializing in the field of osteo-renal diseases, for AC-200 (phosphatonin), a drug candidate being developed by Acologix. AC-200 is a recombinant protein intended for the treatment of hyperphosphatemia.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES